Mesa Laboratories, Inc. (NASDAQ:MLAB) Stake Lowered by Teton Advisors Inc.

Teton Advisors Inc. reduced its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 25.0% during the 4th quarter, HoldingsChannel reports. The fund owned 3,000 shares of the medical instruments supplier’s stock after selling 1,000 shares during the period. Teton Advisors Inc.’s holdings in Mesa Laboratories were worth $314,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Quadrant Capital Group LLC boosted its holdings in Mesa Laboratories by 515.6% during the fourth quarter. Quadrant Capital Group LLC now owns 277 shares of the medical instruments supplier’s stock valued at $29,000 after acquiring an additional 232 shares during the period. Louisiana State Employees Retirement System acquired a new position in shares of Mesa Laboratories during the fourth quarter valued at about $272,000. SG Americas Securities LLC raised its position in Mesa Laboratories by 23.1% in the third quarter. SG Americas Securities LLC now owns 2,928 shares of the medical instruments supplier’s stock worth $308,000 after purchasing an additional 549 shares in the last quarter. Illinois Municipal Retirement Fund acquired a new position in Mesa Laboratories in the third quarter worth about $341,000. Finally, Jump Financial LLC raised its position in Mesa Laboratories by 77.4% in the third quarter. Jump Financial LLC now owns 3,293 shares of the medical instruments supplier’s stock worth $346,000 after purchasing an additional 1,437 shares in the last quarter. 90.60% of the stock is currently owned by institutional investors.

Mesa Laboratories Stock Performance

Shares of NASDAQ:MLAB traded up $3.19 on Thursday, reaching $113.37. 39,512 shares of the company’s stock were exchanged, compared to its average volume of 47,367. The company has a fifty day moving average of $105.29 and a 200-day moving average of $99.74. Mesa Laboratories, Inc. has a twelve month low of $82.86 and a twelve month high of $172.80. The company has a market capitalization of $611.06 million, a price-to-earnings ratio of 648.16 and a beta of 0.82. The company has a current ratio of 2.68, a quick ratio of 1.86 and a debt-to-equity ratio of 0.58.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings data on Monday, February 5th. The medical instruments supplier reported $1.46 EPS for the quarter, missing the consensus estimate of $1.47 by ($0.01). The company had revenue of $53.47 million during the quarter, compared to the consensus estimate of $54.90 million. Mesa Laboratories had a net margin of 0.45% and a return on equity of 7.41%. On average, research analysts predict that Mesa Laboratories, Inc. will post 6.15 EPS for the current fiscal year.

Mesa Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Friday, May 31st will be issued a $0.16 dividend. The ex-dividend date is Friday, May 31st. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.56%. Mesa Laboratories’s dividend payout ratio is presently 376.49%.

Analyst Upgrades and Downgrades

Separately, Evercore ISI lifted their target price on shares of Mesa Laboratories from $124.00 to $130.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions.